Stratview Research has launched a new report, titled Biodegradable Stents Market, By Biomaterial (Polymeric Stents, Metallic Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-User (Hospital, Cardiac Centers) and Region.
Covid-19 Impact Analysis:
Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.
According to the report, The Biodegradable Stents Market is estimated to grow from USD 288.7 million in 2020 to USD 490.2 million by 2026 at a healthy CAGR of 9.4% during the forecast period.
Market Segments' Analysis
Based on biomaterial, the market has been classified into polymeric stents and metallic stents. The polymeric stents segment accounted for a substantial market share in 2020. This is mainly ascribed to an increase in the usage of polymeric stents by several physicians, companies, and patients due to less inflammatory response, and low risk of associated complications. Also, research is still conducted on polymeric stent materials for the development of the novel bioabsorbable stents, which possess a low risk for restenosis and late-stent thrombosis, which further bolsters the segment growth.
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the surge in prevalence of cardiovascular disease, rise in the number of approval for novel bioabsorbable stents, the large presence of advanced healthcare infrastructure, as well as presence of major market participants. In addition, the surge in R&D activities in the healthcare sector and enhancement of healthcare infrastructure, and presence of major players operating in the region, which further proliferates the regional growth.
Key Players
The following are the key players in the biodegradable stents market
· Boston Scientific Corporation (US)
· Arterius Limited (UK)
· Elixir Medical Corporation (US)
· Kyoto Medical Planning Co. Ltd (Japan)
· Terumo Corporation (Japan)
· Abbott Laboratories Inc. (US)
· Amaranth Medical (US)
· Biotronik (Germany)
· Meril Life Sciences Pvt. Ltd (India)
· Reva Medical (US)
Frequently Asked Questions –
This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:
- What is the current and future market size of biodegradable stents market?
- How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
- What will be the short and long-term effects of the pandemic?
- How are other market factors affecting the market dynamics?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the biodegradable stents market competition?
- What are the key emerging trends and unmet needs in the present market?
- What are the strategic growth opportunities and key success factors?
Read the full report: https://www.stratviewresearch.com/Request-Sample/2420/Biodegradable-Stents-Market.html#form
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to sales@stratviewresearch.com. You may also connect with our market experts at +1-313-307-4176.
About Stratview Research
Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.
biodegradable stents market
